Literature DB >> 21384530

Paper 3: EUROCAT data quality indicators for population-based registries of congenital anomalies.

Maria Loane1, Helen Dolk, Ester Garne, Ruth Greenlees.   

Abstract

The European Surveillance of Congenital Anomalies (EUROCAT) network of population-based congenital anomaly registries is an important source of epidemiologic information on congenital anomalies in Europe covering live births, fetal deaths from 20 weeks gestation, and terminations of pregnancy for fetal anomaly. EUROCAT's policy is to strive for high-quality data, while ensuring consistency and transparency across all member registries. A set of 30 data quality indicators (DQIs) was developed to assess five key elements of data quality: completeness of case ascertainment, accuracy of diagnosis, completeness of information on EUROCAT variables, timeliness of data transmission, and availability of population denominator information. This article describes each of the individual DQIs and presents the output for each registry as well as the EUROCAT (unweighted) average, for 29 full member registries for 2004-2008. This information is also available on the EUROCAT website for previous years. The EUROCAT DQIs allow registries to evaluate their performance in relation to other registries and allows appropriate interpretations to be made of the data collected. The DQIs provide direction for improving data collection and ascertainment, and they allow annual assessment for monitoring continuous improvement. The DQI are constantly reviewed and refined to best document registry procedures and processes regarding data collection, to ensure appropriateness of DQI, and to ensure transparency so that the data collected can make a substantial and useful contribution to epidemiologic research on congenital anomalies.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21384530     DOI: 10.1002/bdra.20779

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  18 in total

1.  Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening.

Authors:  Maria Loane; Joan K Morris; Marie-Claude Addor; Larraitz Arriola; Judith Budd; Berenice Doray; Ester Garne; Miriam Gatt; Martin Haeusler; Babak Khoshnood; Kari Klungsøyr Melve; Anna Latos-Bielenska; Bob McDonnell; Carmel Mullaney; Mary O'Mahony; Annette Queisser-Wahrendorf; Judith Rankin; Anke Rissmann; Catherine Rounding; Joaquin Salvador; David Tucker; Diana Wellesley; Lyubov Yevtushok; Helen Dolk
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

2.  EUROmediCAT signal detection: a systematic method for identifying potential teratogenic medication.

Authors:  Johannes M Luteijn; Joan K Morris; Ester Garne; Joanne Given; Lolkje de Jong-van den Berg; Marie-Claude Addor; Marian Bakker; Ingeborg Barisic; Miriam Gatt; Kari Klungsoyr; Anna Latos-Bielenska; Nathalie Lelong; Vera Nelen; Amanda Neville; Mary O'Mahony; Anna Pierini; David Tucker; Hermien de Walle; Awi Wiesel; Maria Loane; Helen Dolk
Journal:  Br J Clin Pharmacol       Date:  2016-08-04       Impact factor: 4.335

3.  Identifying signals of potentially harmful medications in pregnancy: use of the double false discovery rate method to adjust for multiple testing.

Authors:  Alana Cavadino; David Prieto-Merino; Joan K Morris
Journal:  Br J Clin Pharmacol       Date:  2018-11-26       Impact factor: 4.335

4.  Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework.

Authors:  Françoise Renaud; Lynne M Mofenson; Charlotte Bakker; Helen Dolk; Valeriane Leroy; Angelina Namiba; Leyla Sahin; Roger Shapiro; Amy Slogrove; Claire Thorne; Marissa Vicari; Daniel Low-Beer; Meg Doherty
Journal:  J Int AIDS Soc       Date:  2022-07       Impact factor: 6.707

5.  Detection and investigation of temporal clusters of congenital anomaly in Europe: seven years of experience of the EUROCAT surveillance system.

Authors:  Helen Dolk; Maria Loane; Conor Teljeur; James Densem; Ruth Greenlees; Nichola McCullough; Joan Morris; Vera Nelen; Fabrizio Bianchi; Alan Kelly
Journal:  Eur J Epidemiol       Date:  2015-04-04       Impact factor: 8.082

Review 6.  Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions.

Authors:  Flor M Munoz; Linda O Eckert; Mark A Katz; Philipp Lambach; Justin R Ortiz; Jorgen Bauwens; Jan Bonhoeffer
Journal:  Vaccine       Date:  2015-09-19       Impact factor: 3.641

7.  Development and implementation of the first national data quality standards for population-based birth defects surveillance programs in the United States.

Authors:  Marlene Anderka; Cara T Mai; Paul A Romitti; Glenn Copeland; Jennifer Isenburg; Marcia L Feldkamp; Sergey Krikov; Russel Rickard; Richard S Olney; Mark A Canfield; Carol Stanton; Bridget Mosley; Russell S Kirby
Journal:  BMC Public Health       Date:  2015-09-19       Impact factor: 3.295

8.  Trends in the prevalences of congenital anomalies and age at motherhood in a Southern European region: a population-based study.

Authors:  K Cambra; B Ibañez; D Urzelai; I Portillo; I Montoya; S Esnaola; F B Cirarda
Journal:  BMJ Open       Date:  2014-03-03       Impact factor: 2.692

9.  Sex prevalence of major congenital anomalies in the United Kingdom: a national population-based study and international comparison meta-analysis.

Authors:  Rachel Sokal; Laila J Tata; Kate M Fleming
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-02-12

10.  Long term trends in prevalence of neural tube defects in Europe: population based study.

Authors:  Babak Khoshnood; Maria Loane; Hermien de Walle; Larraitz Arriola; Marie-Claude Addor; Ingeborg Barisic; Judit Beres; Fabrizio Bianchi; Carlos Dias; Elizabeth Draper; Ester Garne; Miriam Gatt; Martin Haeusler; Kari Klungsoyr; Anna Latos-Bielenska; Catherine Lynch; Bob McDonnell; Vera Nelen; Amanda J Neville; Mary T O'Mahony; Annette Queisser-Luft; Judith Rankin; Anke Rissmann; Annukka Ritvanen; Catherine Rounding; Antonin Sipek; David Tucker; Christine Verellen-Dumoulin; Diana Wellesley; Helen Dolk
Journal:  BMJ       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.